Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| cystic fibrosis |
📓
Epidemiology, Biology, and Impact of Clonal Pseudomonas aeruginosa Infections in Cystic Fibrosis. Clinical microbiology reviews (Clin Microbiol Rev ) Vol: 31 Issue 4 Pages: Pub: 2018 Oct Epub: 2018 Aug 29 Authors Parkins MD , Somayaji R , Waters VJ , Html Article Publication |
| cystic fibrosis |
📓
Pseudomonas pharyngitis in a cystic fibrosis patient. Respirology case reports (Respirol Case Rep ) Vol: 6 Issue 5 Pages: e00325 Pub: 2018 Jul Epub: 2018 Apr 27 Authors Pradeepan S , Wark P , Html Article Publication |
| cystic fibrosis |
📓
The importance of early diagnosis of Mycobacterium abscessus complex in patients with cystic fibrosis. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica (APMIS ) Vol: 126 Issue 12 Pages: 885-891 Pub: 2018 Dec Epub: Authors Ravnholt C , Kolpen M , Skov M , Moser C , Katzenstein TL , Pressler T , Høiby N , Qvist T , Publication |
| cystic fibrosis |
📓
Pseudomonas aeruginosa colonization causes PD-L1 overexpression on monocytes, impairing the adaptive immune response in patients with cystic fibrosis. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society (J Cyst Fibros ) Vol: Issue Pages: Pub: 2018 Nov 12 Epub: 2018 Nov 12 Authors Avendaño-Ortiz J , Llanos-González E , Toledano V , Del Campo R , Cubillos-Zapata C , Lozano-Rodríguez R , Ismail A , Prados C , Gómez-Campelo P , Aguirre LA , García-Río F , López-Collazo E , Publication |
| cystic fibrosis |
📓
AR-13 reduces antibiotic-resistant bacterial burden in cystic fibrosis phagocytes and improves cystic fibrosis transmembrane conductance regulator function. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society (J Cyst Fibros ) Vol: Issue Pages: Pub: 2018 Oct 23 Epub: 2018 Oct 23 Authors Assani K , Shrestha CL , Rinehardt H , Zhang S , Robledo-Avila F , Wellmerling J , Partida-Sanchez S , Cormet-Boyaka E , Reynolds SD , Schlesinger LS , Kopp BT , Publication |
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
